Parathyroid Hormone Market Report 2026

Parathyroid Hormone Market Overview

• Parathyroid Hormone market size has reached to $2.51 billion in 2025 • Expected to grow to $4.4 billion in 2030 at a compound annual growth rate (CAGR) of 11.9% • Growth Driver: Growth Of The Parathyroid Hormone Market Driven By Increasing Geriatric Population • Market Trend: Focus On Biosimilars In Parathyroid Hormone Treatments For Enhanced Patient Care • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Parathyroid Hormone Market?

Parathyroid hormone refers to a substance produced by the parathyroid gland that aids in the body's storage and utilization of calcium. High blood calcium levels are a result of parathyroid hormone levels that are greater than usual and could be a disease indicator. It is also known as PTH, parathyrin, and parathormone. The main types of products in parathyroid hormone are recombinant parathyroid hormone and parathyroid hormone analogs. Recombinant parathyroid hormone, a mimic of parathyroid hormone, is used to treat osteoporosis. The different types of diseases include hypocalcemia, and hypoparathyroidism and are used in various sectors, such as hospitals, clinics, and others.

What Is The Parathyroid Hormone Market Growth Forecast?

The parathyroid hormone market size is expected to see rapid growth in the next few years. It will grow to $4.4 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to development of advanced parathyroid hormone analogues, rising adoption of personalized medicine approaches, expansion of hospital and specialty clinics, integration of digital patient monitoring tools, increasing government and healthcare initiatives for hypocalcemia and hypoparathyroidism. Major trends in the forecast period include rising incidence of hypocalcemia and hypoparathyroidism, increasing use of recombinant parathyroid hormone therapies, growth in parathyroid hormone analogues for personalized treatment, expansion of hospital and clinic-based parathyroid care programs, focus on post-surgical management and vitamin d supplementation.

Global Parathyroid Hormone Market Segmentation

1) By Disease Type: Hypocalcemia, Hypoparathyroidism 2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues 3) By End-User: Hospitals, Clinics, Other End-Users Subsegments: 1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency 2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism

What Is The Driver Of The Parathyroid Hormone Market?

The increasing geriatric population is expected to propel the growth of the parathyroid hormone market going forward. The geriatric population refers to older adults, typically aged 65 and older, who may experience age-related health challenges and require specialized care and support. This demographic shift can be attributed to increased life expectancy, advancements in healthcare, and declining birth rates, resulting in a higher proportion of elderly individuals in society. Parathyroid hormone is vital for the geriatric population as it regulates calcium levels and bone metabolism, helping to prevent osteoporosis and fractures, which are common in older adults. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the increasing geriatric population is driving the growth of the parathyroid hormone industry.

Key Players In The Global Parathyroid Hormone Market

Major companies operating in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

Global Parathyroid Hormone Market Trends and Insights

Major companies operating in the parathyroid hormone market are focusing on developing biosimilars of parathyroid-based drugs, such as prodrugs of parathyroid hormone (PTH), to enhance treatment options. A prodrug of parathyroid hormone (PTH) is an inactive compound that transforms into active parathyroid hormone after administration, enabling prolonged release and stable therapeutic outcomes for calcium regulation and bone health. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company announced that the Food & Drug Administration (FDA), approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma, the manufacturer, provides patient support through its ascendis signature access program (A.S.A.P.) program, but users must regularly monitor serum calcium levels for potential hypercalcemia or hypocalcemia.

What Are Latest Mergers And Acquisitions In The Parathyroid Hormone Market?

In November 2023, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, formed a strategic partnership with Teijin Limited in Japan to advance the development and commercialization of innovative therapies. The collaboration aims to expand access to Ascendis Pharma’s pipeline products, enhance patient care in Japan, and foster innovation and growth in the rare disease and endocrine therapeutics market. Teijin Limited is a Japan-based healthcare and pharmaceutical company focused on delivering advanced therapies and solutions to address unmet medical needs.

Regional Insights

North America was the largest region in the parathyroid hormone market in 2025. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Parathyroid Hormone Market?

The parathyroid hormone market consists of sales of parathormone and calcitonin. Values in this market are """"factory gate values,"""" that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Parathyroid Hormone Market Report 2026?

The parathyroid hormone market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid hormone industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.